Oxford BioDynamics (STU:LMQ) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Oxford BioDynamics Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

Oxford BioDynamics Business Description

Other Exchanges OXBOF:USAOBD:UK
Address John Smith Drive, 3140 Rowan Place, Oxford Business Park South, Oxford, GBR, OX4 2WB
Oxford BioDynamics PLC is a UK-based biotechnology company that develops and commercializes precision medicine diagnostics based on its proprietary EpiSwitch platform, a chromatin-conformation biomarker technology. Its clinical products include the EpiSwitch PSE blood test for prostate cancer detection and the EpiSwitch CiRT test, which predicts patient response to immune checkpoint inhibitors. The company also pursues biomarker discovery and development programs, including work in amyotrophic lateral sclerosis and other conditions, often through partnerships with pharmaceutical and academic collaborators. Revenue comes from sales of its diagnostic tests, biomarker research and development services, and licensing or collaboration agreements. Its primary commercial market is the United States, with additional activity in the United Kingdom and other territories. Oxford BioDynamics operates laboratories and offices in the UK and the US, serving clinicians, patients, and pharmaceutical partners seeking molecular diagnostics that inform treatment decisions.